Skip to main content
. 2015 Jan 14;21(2):667–674. doi: 10.3748/wjg.v21.i2.667

Table 3.

Recurrence and associated factors (n = 90)

No recurred (n = 84) Recurred (n = 6) P value
Age (yr) 57.8 ± 12.0 64.8 ± 7.4 0.159
Sex 1.000
Male 52 (61.9) 4 (66.7)
Female 32 (38.1) 2 (33.3)
Depth of invasion 1.000
Mucosa 12 (14.3) 0 (0)
Submucosa 72 (85.7) 6 (100)
Tumor size (cm) 4.7 ± 2.5 3.7 ± 1.27 0.321
Histology 0.681
Differentiated 44 (52.4) 4 (66.7)
Undifferentiated 40 (47.5) 2 (33.3)
Lauren 0.396
Intestinal 49 (58.3) 5 (83.3)
Diffuse, mixed 35 (41.7) 1 (16.7)
Lymphovascular invasion 0.032
Absent 40 (47.6) 0 (0)
Present 44 (52.4) 6 (100)
Metastatic LNs (n) 2.0 ± 1.3 2.2 ± 1.2 0.816
Classification of nodal metastasis 0.041
Micrometastasis 37 (44.0) 0 (0)
Macrometastasis 47 (56.0) 6 (100)
Japanese N2 station involvement1 0.127
No 58 (85.3) 2 (50.0)
Yes 10 (14.7) 2 (50.0)
Main tumor burden in LN (mm) 3.0 ± 4.1 4.0 ± 1.5 0.594
Pattern of metastasis in LNs 0.450
Single cluster 28 (33.3) 4 (66.7)
Multiple cluster 54 (64.3) 1 (16.7)
Diffuse 2 (2.4) 1 (16.7)
Location of metastasis in LNs 0.090
Marginal sinus 31 (36.9) 0 (0)
Non marginal sinus 53 (63.1) 6 (100)
Gastric resection 1.000
Open subtotal 63 (75.0) 4 (66.7)
Open total 7 (8.3) 1 (16.7)
LADG 14 (16.7) 1 (16.7)
Lymph node dissection 1.000
D1 + β 28 (33.3) 2 (33.3)
D2 56 (66.7) 4 (66.7)
Dissected LNs (n) 37.4 ± 13.8 41.0 ± 16.4 0.538
Adjuvant chemotherapy 0.660
No 30 (35.7) 1 (16.7)
Yes 54 (64.3) 5 (83.3)
Ki-67 (primary tumor)1
Positive cell 61.3% ± 22.1% 58.3% ± 24.6% 0.748
TUNEL (primary tumor)1
Positive cell 3.6% ± 3.9% 4.6% ± 2.2% 0.552
Ki-67 (lymph node)1
Positive cell 35.0% ± 23.5% 35.0% ± 10.8% 0.996
TUNEL (lymph node)1
Positive cell 2.3% ± 3.2% 2.8% ± 1.1% 0.720
1

Available data only. Data are expressed as absolute numbers (percentage) or mean ± SD. LN: Lymph node; LADG: Laparoscopically assisted distal gastrectomy; TUNEL: Terminal deoxynucleotidyl transferase dUTP nick end labeling.